Barclays analyst J. David Anderson raised the firm’s price target on NOV Inc. to $20 from $17 and keeps an Underweight rating on the shares. The company posted a solid Q2 with an EBITDA beat, impressive order inbound, higher margins and strong free cash flow, but these were offset by a softer second half of 2024 guide, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV: